neurochase limited
neurochase limited Company Information
Company Number
12428919
Next Accounts
Dec 2025
Shareholders
neurochase holdings limited
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
st brandon's house, 29 great george street, bristol, BS1 5QT
Website
neurochase.comneurochase limited Estimated Valuation
Pomanda estimates the enterprise value of NEUROCHASE LIMITED at £743.5k based on a Turnover of £507.1k and 1.47x industry multiple (adjusted for size and gross margin).
neurochase limited Estimated Valuation
Pomanda estimates the enterprise value of NEUROCHASE LIMITED at £1.7m based on an EBITDA of £303.3k and a 5.48x industry multiple (adjusted for size and gross margin).
neurochase limited Estimated Valuation
Pomanda estimates the enterprise value of NEUROCHASE LIMITED at £3.3m based on Net Assets of £1.8m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Neurochase Limited Overview
Neurochase Limited is a live company located in bristol, BS1 5QT with a Companies House number of 12428919. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2020, it's largest shareholder is neurochase holdings limited with a 100% stake. Neurochase Limited is a young, small sized company, Pomanda has estimated its turnover at £507.1k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Neurochase Limited Health Check
Pomanda's financial health check has awarded Neurochase Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
4 Weak
Size
annual sales of £507.1k, make it smaller than the average company (£3.5m)
- Neurochase Limited
£3.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a similar rate (13%)
- Neurochase Limited
13% - Industry AVG
Production
with a gross margin of 54.5%, this company has a comparable cost of product (54.5%)
- Neurochase Limited
54.5% - Industry AVG
Profitability
an operating margin of 59.1% make it more profitable than the average company (-7.8%)
- Neurochase Limited
-7.8% - Industry AVG
Employees
with 5 employees, this is below the industry average (46)
5 - Neurochase Limited
46 - Industry AVG
Pay Structure
on an average salary of £79.9k, the company has an equivalent pay structure (£79.9k)
- Neurochase Limited
£79.9k - Industry AVG
Efficiency
resulting in sales per employee of £101.4k, this is less efficient (£124.5k)
- Neurochase Limited
£124.5k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (53 days)
- Neurochase Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 560 days, this is slower than average (53 days)
- Neurochase Limited
53 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Neurochase Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 52 weeks, this is more cash available to meet short term requirements (34 weeks)
52 weeks - Neurochase Limited
34 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 79.5%, this is a higher level of debt than the average (50.9%)
79.5% - Neurochase Limited
50.9% - Industry AVG
NEUROCHASE LIMITED financials
Neurochase Limited's latest turnover from March 2024 is estimated at £507.1 thousand and the company has net assets of £1.8 million. According to their latest financial statements, Neurochase Limited has 5 employees and maintains cash reserves of £1.9 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Jan 2022 | Jan 2021 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | 5 | 7 | 4 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Jan 2022 | Jan 2021 | |
|---|---|---|---|---|
| Tangible Assets | 12,370 | 13,758 | 998 | |
| Intangible Assets | 5,870,248 | 3,093,989 | 776,856 | 48,973 |
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 5,882,618 | 3,107,747 | 777,854 | 48,973 |
| Stock & work in progress | ||||
| Trade Debtors | 7,731 | 46,350 | 78,183 | 53,210 |
| Group Debtors | ||||
| Misc Debtors | 1,062,006 | 861,940 | 232,434 | 75,500 |
| Cash | 1,947,332 | 4,120,188 | 99,749 | 408,519 |
| misc current assets | ||||
| total current assets | 3,017,069 | 5,028,478 | 410,366 | 537,229 |
| total assets | 8,899,687 | 8,136,225 | 1,188,220 | 586,202 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 354,718 | 424,975 | 186,260 | |
| Group/Directors Accounts | 163,215 | 259,389 | 71,299 | 5,606 |
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 1,400,317 | 5,246,404 | 215,948 | 486,208 |
| total current liabilities | 1,918,250 | 5,930,768 | 473,507 | 491,814 |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | 3,840,362 | |||
| provisions | 1,315,005 | 723,459 | ||
| total long term liabilities | 5,155,367 | 723,459 | ||
| total liabilities | 7,073,617 | 6,654,227 | 473,507 | 491,814 |
| net assets | 1,826,070 | 1,481,998 | 714,713 | 94,388 |
| total shareholders funds | 1,826,070 | 1,481,998 | 714,713 | 94,388 |
| Mar 2024 | Mar 2023 | Jan 2022 | Jan 2021 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | 3,763 | 1,313 | 90 | |
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | 161,447 | 597,673 | 181,907 | 128,710 |
| Creditors | -70,257 | 238,715 | 186,260 | |
| Accruals and Deferred Income | -3,846,087 | 5,030,456 | -270,260 | 486,208 |
| Deferred Taxes & Provisions | 591,546 | 723,459 | ||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | -96,174 | 188,090 | 65,693 | 5,606 |
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | 3,840,362 | |||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -2,172,856 | 4,020,439 | -308,770 | 408,519 |
| overdraft | ||||
| change in cash | -2,172,856 | 4,020,439 | -308,770 | 408,519 |
neurochase limited Credit Report and Business Information
Neurochase Limited Competitor Analysis
Perform a competitor analysis for neurochase limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in BS1 area or any other competitors across 12 key performance metrics.
neurochase limited Ownership
NEUROCHASE LIMITED group structure
Neurochase Limited has no subsidiary companies.
neurochase limited directors
Neurochase Limited currently has 5 directors. The longest serving directors include Mr Adrian Dawkes (Jan 2020) and Prof Steven Gill (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adrian Dawkes | United Kingdom | 63 years | Jan 2020 | - | Director |
| Prof Steven Gill | England | 68 years | Jan 2020 | - | Director |
| Ms Theresa Bruce | England | 60 years | Jan 2020 | - | Director |
| Mrs Sharon Kane | England | 52 years | Aug 2021 | - | Director |
| Mr Keith Murdoch | England | 68 years | Jul 2022 | - | Director |
P&L
March 2024turnover
507.1k
-31%
operating profit
299.5k
0%
gross margin
54.5%
+1.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.8m
+0.23%
total assets
8.9m
+0.09%
cash
1.9m
-0.53%
net assets
Total assets minus all liabilities
neurochase limited company details
company number
12428919
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
January 2020
age
5
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
xced labs limited (October 2020)
accountant
-
auditor
-
address
st brandon's house, 29 great george street, bristol, BS1 5QT
Bank
-
Legal Advisor
-
neurochase limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to neurochase limited.
neurochase limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NEUROCHASE LIMITED. This can take several minutes, an email will notify you when this has completed.
neurochase limited Companies House Filings - See Documents
| date | description | view/download |
|---|
